News

Drugmaker-telehealth deals risk unnecessary prescribing, senators’ probe finds
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
Zacks.com on MSN4h
Can Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?
Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
India Today on MSN19h
US employers to cut health benefits amid soaring weight-loss drug costs: Survey
Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...
Many US employers plan to pare health benefits as weight-loss spending soars
NEW YORK (Reuters) -More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new ...